Related Experiment Videos
[Melanoma: a new interferon is coming ... handle with care!]
1Département de cancérologie médicale, Centre Léon-Bérard, Lyon, France.
Bulletin Du Cancer
|April 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Uveal melanoma: In the era of new treatments.
Cancer treatment reviews·2023
TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma.
European journal of cancer (Oxford, England : 1990)·2014
[Guidelines for the essential data entry in the European Bone Marrow Transplant Registry].
Bulletin du cancer·2026
[Transoral robotic surgery in head and neck cancers].
Bulletin du cancer·2026
Research Progress in Pharmacological Targeted Therapy for Myasthenia Gravis.
Journal of inflammation research·2026
Adverse effects of vanzacaftor-tezacaftor-deutivacaftor in a cystic fibrosis population: A case series.
Respiratory medicine case reports·2026